Emergent BioSolutions
EBS
#6766
Rank
โ‚น57.07 B
Marketcap
โ‚น1,070
Share price
-1.24%
Change (1 day)
38.06%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น131.33 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are โ‚น131.33 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น119.21 B-21.45%
2023-12-31โ‚น151.77 B-42.07%
2022-12-31โ‚น262.01 B19.02%
2021-12-31โ‚น220.14 B4.4%
2020-12-31โ‚น210.85 B27.05%
2019-12-31โ‚น165.96 B6.46%
2018-12-31โ‚น155.88 B128.13%
2017-12-31โ‚น68.33 B3.65%
2016-12-31โ‚น65.92 B-4.38%
2015-12-31โ‚น68.94 B15.89%
2014-12-31โ‚น59.49 B53.67%
2013-12-31โ‚น38.71 B25.31%
2012-12-31โ‚น30.89 B6.79%
2011-12-31โ‚น28.92 B29.04%
2010-12-31โ‚น22.41 B40.18%
2009-12-31โ‚น15.99 B14.43%
2008-12-31โ‚น13.97 B30.21%
2007-12-31โ‚น10.73 B1.72%
2006-12-31โ‚น10.55 B133.72%
2005-12-31โ‚น4.51 B50.97%
2004-12-31โ‚น2.99 B
2002-12-31โ‚น1.09 B-10.91%
2001-12-31โ‚น1.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
โ‚น11.645 T 8,766.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น20.82 B-84.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.412 T 5,544.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น58.29 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.764 T 14,186.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.582 T 2,627.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚น1.01 B-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA